132 related articles for article (PubMed ID: 38453410)
1. Arterial Spin-Labeling and DSC Perfusion Metrics Improve Agreement in Neuroradiologists' Clinical Interpretations of Posttreatment High-Grade Glioma Surveillance MR Imaging-An Institutional Experience.
Yamin G; Tranvinh E; Lanzman BA; Tong E; Hashmi SS; Patel CB; Iv M
AJNR Am J Neuroradiol; 2024 Apr; 45(4):453-460. PubMed ID: 38453410
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Accuracy of Arterial Spin-Labeling, Dynamic Contrast-Enhanced, and DSC Perfusion Imaging in the Diagnosis of Recurrent High-Grade Gliomas: A Prospective Study.
Nguyen TB; Zakhari N; Velasco Sandoval S; Guarnizo-Capera A; Alexios Gulak M; Woulfe J; Jansen G; Thornhill R; Majtenyi N; Cron GO
AJNR Am J Neuroradiol; 2023 Feb; 44(2):134-142. PubMed ID: 36702501
[TBL] [Abstract][Full Text] [Related]
3. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
[TBL] [Abstract][Full Text] [Related]
4. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
[TBL] [Abstract][Full Text] [Related]
6. Comparison of ASL and DSC perfusion methods in the evaluation of response to treatment in patients with a history of treatment for malignant brain tumor.
Bayraktar ES; Duygulu G; Çetinoğlu YK; Gelal MF; Apaydın M; Ellidokuz H
BMC Med Imaging; 2024 Mar; 24(1):70. PubMed ID: 38519901
[TBL] [Abstract][Full Text] [Related]
7. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma.
Hu LS; Kelm Z; Korfiatis P; Dueck AC; Elrod C; Ellingson BM; Kaufmann TJ; Eschbacher JM; Karis JP; Smith K; Nakaji P; Brinkman D; Pafundi D; Baxter LC; Erickson BJ
AJNR Am J Neuroradiol; 2015 Dec; 36(12):2242-9. PubMed ID: 26359151
[TBL] [Abstract][Full Text] [Related]
8. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project.
Schmainda KM; Prah MA; Rand SD; Liu Y; Logan B; Muzi M; Rane SD; Da X; Yen YF; Kalpathy-Cramer J; Chenevert TL; Hoff B; Ross B; Cao Y; Aryal MP; Erickson B; Korfiatis P; Dondlinger T; Bell L; Hu L; Kinahan PE; Quarles CC
AJNR Am J Neuroradiol; 2018 Jun; 39(6):1008-1016. PubMed ID: 29794239
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three different MR perfusion techniques and MR spectroscopy for multiparametric assessment in distinguishing recurrent high-grade gliomas from stable disease.
Seeger A; Braun C; Skardelly M; Paulsen F; Schittenhelm J; Ernemann U; Bisdas S
Acad Radiol; 2013 Dec; 20(12):1557-65. PubMed ID: 24200483
[TBL] [Abstract][Full Text] [Related]
10. A radiomics-based comparative study on arterial spin labeling and dynamic susceptibility contrast perfusion-weighted imaging in gliomas.
Hashido T; Saito S; Ishida T
Sci Rep; 2020 Apr; 10(1):6121. PubMed ID: 32273523
[TBL] [Abstract][Full Text] [Related]
11. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
12. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
13. Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.
Hoxworth JM; Eschbacher JM; Gonzales AC; Singleton KW; Leon GD; Smith KA; Stokes AM; Zhou Y; Mazza GL; Porter AB; Mrugala MM; Zimmerman RS; Bendok BR; Patra DP; Krishna C; Boxerman JL; Baxter LC; Swanson KR; Quarles CC; Schmainda KM; Hu LS
AJNR Am J Neuroradiol; 2020 Mar; 41(3):408-415. PubMed ID: 32165359
[TBL] [Abstract][Full Text] [Related]
14. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
[TBL] [Abstract][Full Text] [Related]
15. Assessment of brain tumors by magnetic resonance dynamic susceptibility contrast perfusion-weighted imaging and computed tomography perfusion: a comparison study.
Scola E; Desideri I; Bianchi A; Gadda D; Busto G; Fiorenza A; Amadori T; Mancini S; Miele V; Fainardi E
Radiol Med; 2022 Jun; 127(6):664-672. PubMed ID: 35441970
[TBL] [Abstract][Full Text] [Related]
16. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
[TBL] [Abstract][Full Text] [Related]
17. Perfusion MRI-Based Fractional Tumor Burden Differentiates between Tumor and Treatment Effect in Recurrent Glioblastomas and Informs Clinical Decision-Making.
Iv M; Liu X; Lavezo J; Gentles AJ; Ghanem R; Lummus S; Born DE; Soltys SG; Nagpal S; Thomas R; Recht L; Fischbein N
AJNR Am J Neuroradiol; 2019 Oct; 40(10):1649-1657. PubMed ID: 31515215
[TBL] [Abstract][Full Text] [Related]
18. Qualitative Assessment of Advanced MRI in Post-Treatment High Grade Gliomas Follow Up: Do We Agree?
Zakhari N; Taccone M; Torres C; Chakraborty S; Sinclair J; Woulfe J; Jansen G; Cron G; Nguyen TB
Can Assoc Radiol J; 2022 Feb; 73(1):187-193. PubMed ID: 33998827
[TBL] [Abstract][Full Text] [Related]
19. Effects of Susceptibility Artifacts on Perfusion MRI in Patients with Primary Brain Tumor: A Comparison of Arterial Spin-Labeling versus DSC.
Maral H; Ertekin E; Tunçyürek Ö; Özsunar Y
AJNR Am J Neuroradiol; 2020 Feb; 41(2):255-261. PubMed ID: 31974077
[TBL] [Abstract][Full Text] [Related]
20. Intravoxel incoherent motion diffusion-weighted imaging analysis of diffusion and microperfusion in grading gliomas and comparison with arterial spin labeling for evaluation of tumor perfusion.
Shen N; Zhao L; Jiang J; Jiang R; Su C; Zhang S; Tang X; Zhu W
J Magn Reson Imaging; 2016 Sep; 44(3):620-32. PubMed ID: 26880230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
